Pan-cancer analysis identifies <i>CDCA3</i> as a novel prognostic marker associated with immune infiltration in lung adenocarcinoma through bioinformatics analysis.

Yang, Hao; Wei, Xueqiang; Zhang, Liren; Xiang, Li; Wang, Ping

Pan-cancer analysis identifies CDCA3 as a novel prognostic marker associated with immune infiltration in lung adenocarcinoma through bioinformatics analysis.

Yang, Hao; Wei, Xueqiang; Zhang, Liren; Xiang, Li; Wang, Ping.

Afiliação

Yang H; Kunming Medical University, Kunming, China.
Wei X; Department of Thoracic Surgery, the Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Zhang L; Department of Thoracic Surgery I, the Third Affiliated Hospital of Kunming Medical University/Yunnan Cancer Hospital, Kunming, China.
Xiang L; Kunming Medical University, Kunming, China.
Wang P; Department of Thoracic Surgery, the Second Affiliated Hospital of Kunming Medical University, Kunming, China.

Transl Cancer Res ; 11(8): 2902-2916, 2022 Aug.

Article em En | MEDLINE | ID: mdl-36093552

Palavras-chave

Cell division cycle-associated protein-3 (CDCA3); competing endogenous RNA (ceRNA); lung adenocarcinoma; prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Transl Cancer Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google